Key Takeaways
- • Intermediate Capital Group (ICG) closed its Europe IX fund at €12 billion, marking the largest co-mingled structured capital fund ever raised globally and significantly exceeding its original €10 billion target by approximately 20 percent.
- • Europe IX represents ICG's largest-ever vintage-to-vintage upsize compared to its predecessor fund, demonstrating substantial investor confidence in the firm's structured capital platform and investment track record.
- • The €12 billion close positions ICG's structured capital strategy as a dominant player in European mid-market and upper mid-market financing, targeting private companies with enterprise values between €100 million and €2 billion.
- • ICG generated €6.1 billion in fundraising across its Structured Capital strategies during the 12-month period ending June 30, 2026, reflecting robust capital deployment momentum across its European Corporate, European Mid-Market, and Asia-Pacific Corporate platforms.
- • The fund close underscores the institutional investor appetite for alternative credit solutions in private markets, particularly for flexible subordinated debt and equity structures in economically resilient mid-market segments.
Summary
Intermediate Capital Group achieved a significant milestone by closing its Europe IX fund at €12 billion, establishing a new record as the largest co-mingled structured capital fund ever raised in the market. The final close substantially exceeded the fund's original €10 billion target, representing an approximately 20 percent upsize that reflects robust institutional investor demand for ICG's structured capital solutions.
Europe IX embodies ICG's largest vintage-to-vintage expansion, marking a substantial increase from its predecessor fund and demonstrating the firm's growing competitive positioning within European structured credit markets. The fund targets high-quality mid-market and upper mid-market private companies with enterprise values ranging from €100 million to €2 billion, providing investors with exposure to locally sourced, directly originated, and privately negotiated transactions across Western Europe, North America, and Asia-Pacific regions.
ICG's broader Structured Capital platform generated €6.1 billion in fundraising commitments during the 12-month period ending June 30, 2026, reflecting sustained capital flows across the firm's European Corporate strategy—which maintains a 37-year track record—alongside its dedicated European Mid-Market and Asia-Pacific Corporate strategies. The Life Sciences strategy within the platform also continues to pursue preclinical and clinical-stage growth opportunities, rounding out ICG's diversified structured capital approach.
The €12 billion close positions Europe IX as a cornerstone vehicle for institutional capital seeking consistent, high returns through market cycles via flexible subordinated debt and equity investments. This achievement reinforces ICG's established track record in direct lending and structured solutions, building upon prior milestones including its €5.2 billion Senior Debt Partners vintage and broader asset management growth trajectory.
Europe IX embodies ICG's largest vintage-to-vintage expansion, marking a substantial increase from its predecessor fund and demonstrating the firm's growing competitive positioning within European structured credit markets. The fund targets high-quality mid-market and upper mid-market private companies with enterprise values ranging from €100 million to €2 billion, providing investors with exposure to locally sourced, directly originated, and privately negotiated transactions across Western Europe, North America, and Asia-Pacific regions.
ICG's broader Structured Capital platform generated €6.1 billion in fundraising commitments during the 12-month period ending June 30, 2026, reflecting sustained capital flows across the firm's European Corporate strategy—which maintains a 37-year track record—alongside its dedicated European Mid-Market and Asia-Pacific Corporate strategies. The Life Sciences strategy within the platform also continues to pursue preclinical and clinical-stage growth opportunities, rounding out ICG's diversified structured capital approach.
The €12 billion close positions Europe IX as a cornerstone vehicle for institutional capital seeking consistent, high returns through market cycles via flexible subordinated debt and equity investments. This achievement reinforces ICG's established track record in direct lending and structured solutions, building upon prior milestones including its €5.2 billion Senior Debt Partners vintage and broader asset management growth trajectory.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.